INDIANAPOLIS and LAS VEGAS Eli Lilly and the Indiana Health Industry Forum will hold a summit on Nov. 13 called, “Building on Indiana’s Strength in Diabetes Research, Diagnostics, and Therapeutics,” to focus on the development of better therapies and diagnostic technologies for the prevention and management of diabetes.
The IHIF is a not-for-profit organization that works to define factors that can lead to economic development success in healthcare for Indiana and then build programs that support the future of the industry in the state.
The summit will be used to connect Indiana resources for the development of diabetes treatments and diagnostics, as well as identify business collaborations. In addition to attendees from academia and pharmaceutical and biotechnology industries, representatives from Indiana state government, venture capital concerns, clinical research organizations, research service companies and advocacy groups will attend.
Also, today in Nevada, Health Innovations, the Nevada Health Care Coalition and Sanofi-Aventis released a new report on the demographics, costs and quality of care for people with Type 2 diabetes.
The Nevada Type 2 Diabetes Report for 2007 gives an overview of patient demographics, hospital and provider charges, and utilization of clinical services and drug therapy for people with Type 2 Diabetes in key local markets in the state of Nevada. The report also provides benchmarks from Phoenix as well as national benchmarks that can help employers and providers better identify opportunities to serve the needs of people with Type 2 diabetes.